NCM
GILD icon

Next Capital Management’s Gilead Sciences GILD Stock Holding History

Next Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-330
Closed -$22K – 463
2019
Q2 		$22K Buy
+330
New +$21.7K 0.01% 273

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Next Capital Management's GILD Position: Q3 2019 in Review

Next Capital Management sold out of Gilead Sciences (GILD) in Q3 2019, closing a stake of 330 shares — an estimated $22K sold.

Next Capital Management first reported a position in GILD in Q2 2019 and held it in 1 quarter. The position peaked at $22K in Q2 2019. 1,463 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • Next Capital Management reported no remaining Gilead Sciences position as of Q3 2019 after selling out during the quarter.
  • Next Capital Management sold 330 Gilead Sciences shares in Q3 2019, an estimated $22K.
  • Next Capital Management first reported a position in Gilead Sciences in Q2 2019 and held it in 1 quarter.
  • Next Capital Management's Gilead Sciences position peaked at $22K in Q2 2019.
  • 1,463 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Next Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.